Edition:
United States

OHR Pharmaceutical Inc (OHRP.OQ)

OHRP.OQ on NASDAQ Stock Exchange Capital Market

0.23USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$0.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
376,911
52-wk High
$2.17
52-wk Low
$0.21

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 0.00 -0.074
FY 2017 Sep '17 0.00 -0.093
Jun '17 0.00 -0.072
Mar '17 0.00 -0.209
Dec 0.00 -0.212
FY 2016 Sep '16 0.00 -0.207
Jun '16 0.00 -0.244
Mar '16 0.00 -0.169
Dec 0.00 -0.202
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Sep-18 1 0.00 0.00 0.00 0.00
Year Ending Sep-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.07 -0.07 -0.07 --
Quarter Ending Jun-18 1 -0.11 -0.11 -0.11 --
Year Ending Sep-18 1 -0.52 -0.52 -0.52 -1.41
Year Ending Sep-19 1 -0.81 -0.81 -0.81 -0.86
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 199.23 33.71
P/E High - Last 5 Yrs. -- 289.53 46.11
P/E Low - Last 5 Yrs. -- 97.02 24.86
Beta 0.03 0.75 0.80
Price to Sales (TTM) -- 144.40 7.31
Price to Book (MRQ) 0.67 20.58 5.12
Price to Tangible Book (MRQ) 2.58 25.44 6.51
Price to Cash Flow (TTM) -- 129.04 25.09
% Owned Institutions 15.36 11.15 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 0.76
Dividend 5 Year Growth Rate -- 1.97 3.95
Payout Ratio(TTM) -- 9.04 20.79

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 80.75 8.78
Sales (TTM) vs TTM 1 Yr. Ago -- 96.50 11.85
Sales - 5 Yr. Growth Rate -- 34.30 8.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 65.23 -65.81 22.75
EPS (TTM) vs TTM 1 Yr. Ago 46.14 -- --
EPS - 5 Yr. Growth Rate -- 48.46 10.31
Capital Spending - 5 Yr. Growth Rate -32.07 45.85 10.43

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.60 2.52
Current Ratio (MRQ) 2.45 6.05 3.60
LT Debt to Equity (MRQ) 0.00 23.27 11.54
Total Debt to Equity (MRQ) 0.00 25.63 14.18
Interest Coverage (TTM) -- -187.29 39.23

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 45.96 54.29
Gross Margin - 5 Yr. Avg. -- 55.59 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -148.41 15.91
Operating Margin (TTM) -- -557.58 4.03
Operating Margin - 5 Yr. Avg. -- -160.26 11.21
Pre-Tax Margin (TTM) -- -529.97 4.75
Pre-Tax Margin - 5 Yr. Avg. -- -166.50 11.54
Net Profit Margin (TTM) -- -518.89 1.38
Net Profit Margin - 5 Yr. Avg. -- -166.55 7.88
Effective Tax Rate (TTM) -- -0.18 31.34
Effective Tax Rate - 5 Yr. Avg. -- 18.25 24.24

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,228,298 803,745,726
Net Income/Employee (TTM) -5,246,675 1,142,384 94,372,716
Receivable Turnover (TTM) -- 6.52 5.54
Inventory Turnover (TTM) -- 2.30 3.44
Asset Turnover (TTM) 0.00 0.40 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -78.96 -0.71 10.45
Return on Assets - 5 Yr. Avg. -61.53 0.88 11.47
Return on Investment (TTM) -91.90 -0.66 13.09
Return on Investment - 5 Yr. Avg. -70.92 4.34 14.86
Return on Equity (TTM) -92.20 -2.84 14.92
Return on Equity - 5 Yr. Avg. -70.97 0.09 16.16
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 35.29 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for OHR Pharmaceutical Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 15.36%
# of Holders: 50
Total Shares Held: 8,674,882
3 Mo. Net Change: -40,000
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.